| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
AngioDynamics, Inc. (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.
Analysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.
On July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.
Shares of AngioDynamics rose 4% to close at $11.17 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
Considering buying ANGO stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Posted In: ANGO
